Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 99.55 | 14.73 |
| PEG Ratio (TTM) | -6.30 | -0.22 |
| P/S Ratio (TTM) | 4.03 | 2.62 |
| P/B Ratio (TTM) | 1.49 | 1.36 |
| P/FCF Ratio (TTM) | -47.58 | 6.04 |
| Price to 5YR AVG Earnings Ratio | 25.76 | 15.00 |
| Price to 5YR AVG FCF Ratio | 20.24 | 9.38 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.15% | 0.94% |
| ROE (TTM) | 1.54% | 9.38% |
| Net Profit Margin (TTM) | 3.93% | 16.48% |
| ROIC 5YR AVG | 5.15% | 17.44% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 95.72% | 73.45% | 31.24% |
| Revenue | 13.76% | 13.78% | 5.82% |
| Net Income | 95.92% | 68.58% | 28.25% |
| Cash Flow | -69.06% | 54.50% | 27.24% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 12.37 |
| Quick Ratio (TTM) | N/A | 12.58 |
| D/E Ratio (TTM) | 1.32 | 1.03 |
| Interest Coverage (TTM) | 0.12 | 0.72 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 1.26 | 0.43 |
| LTL to 5YR AVG FCF | 7.75 | 5.64 |
| Shares Outstanding Growth 5YR AVG | -1.60% | 56.04% |